Jun 27, 2022 7:31pm EDT Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Novel Immunostimulatory Antibody-Drug Conjugates (iADCs)
Jun 03, 2022 4:01pm EDT Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 09, 2022 4:30pm EDT Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones
Apr 29, 2022 5:00pm EDT Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 08, 2022 1:00pm EDT Sutro Biopharma Presents Nonclinical Data for Antibody-Drug Conjugate STRO-002 at the AACR Annual Meeting 2022
Apr 05, 2022 7:00am EDT Sutro Biopharma to Present at the 21st Annual Needham Virtual Healthcare Conference
Mar 30, 2022 4:05pm EDT Sutro Biopharma Presented on Advances in Novel Immunostimulatory Antibody-Drug Conjugate Modality at the 12th Annual World ADC
Mar 03, 2022 7:00am EST Sutro Biopharma to Participate in the Cowen 42nd Annual Healthcare Conference
Feb 28, 2022 4:35pm EST Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anticipated 2022 Milestones
